Conference Coverage

Hormonal Contraceptives May Increase Epileptic Seizures


 

References

More women on hormonal contraceptives also reported having a decrease in seizures after starting contraception, compared with women starting on a nonhormonal method (9.5% vs 5.2%), which resulted in an 85% relative rate increase for decreased seizures. Depot medroxyprogesterone acetate was the only specific hormonal contraceptive that was associated with a higher rate of seizure decreases (95% higher), compared with combined oral pills.

In a second analysis of the results, Dr. Herzog and his associates examined the frequencies of seizure outcomes on hormonal and nonhormonal contraceptives, stratifying by the type of antiepileptic drug the women used when starting a particular contraceptive method. This analysis categorized antiepileptic drugs into the following four types: enzyme-inducing (29%), glucuronidated (such as lamotrigine, 27%), nonenzyme-inducing (such as levetiracetam, 22%), and enzyme-inhibiting (valproate, 8%). A fifth category included women who were not on any antiepileptic drug (14%).

This analysis showed that the frequency of seizure increases was significantly greater with hormonal contraceptive use, compared with nonhormonal methods, across all five subgroups of antiepileptic drug type. In addition, the frequency of seizure increases with hormonal contraceptives differed significantly, depending on which antiepileptic drug type women used, but these significant differences among the antiepileptic drug types also occurred among women who used nonhormonal contraception.Women receiving a nonenzyme-inducing drug when starting a hormonal contraceptive reported the lowest frequency of seizure increases, a rate of 12%. In contrast, women on an enzyme-inhibiting drug, valproate, had the highest rate of increased seizures when starting a hormonal contraceptive: 29%. Women who started hormonal contraception while on valproate thus had about a 2.5-fold relative risk increase for having more seizures, compared with women on a nonenzyme-inducing drug, Dr. Herzog reported.

Physicians “need to be on the lookout for the possibility that seizures could increase when women start a hormonal contraceptive,” he concluded.

Mitchel L. Zoler

Pages

Recommended Reading

Patrick Kwan, MB, PhD
MDedge Neurology
AES: Three studies show generic lamotrigine equals Lamictal
MDedge Neurology
Good luck convincing patients that generics equal brand-name drugs
MDedge Neurology
AES: Sparse evidence hints at epilepsy disease modification
MDedge Neurology
Data Reinforce Signals of Cannabidiol’s Efficacy in Treatment-Resistant Epilepsy
MDedge Neurology
Perception Disparities Between Patients With Seizure Clusters and Clinicians
MDedge Neurology
Continuous IV Therapy May Be Inappropriate for Some Children With Refractory Status Epilepticus
MDedge Neurology
Nocturnal Seizures Impair Memory Performance
MDedge Neurology
Brains of People With Medically Refractory Epilepsy Appear Older on MRI
MDedge Neurology
Electrodermal Biofeedback Effectively Treats Drug-Resistant Epilepsy
MDedge Neurology

Related Articles